Gene · 10057
Papers1,907
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,907
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The characterization of the sensitive ovarian cancer cell lines A2780 and W1 in response to ovarian CAFs. | Biochem Biophys Res Commun | 2023 | 37088000 | PubTator, text mining | PubMed |
| LncRNA model predicts liver cancer drug resistance and validate in vitro experiments. | Front Cell Dev Biol | 2023 | 37077416 | PubTator, text mining | PubMed |
| Mechanisms involved in cancer stem cell resistance in head and neck squamous cell carcinoma. | Cancer Drug Resist | 2023 | 37065869 | PubTator, text mining | PubMed |
| Current Knowledge about the Impact of Microgravity on Gene Regulation. | Cells | 2023 | 37048115 | PubTator, text mining | PubMed |
| A hydrogel model of the human blood-brain barrier using differentiated stem cells. | PLoS One | 2023 | 37014916 | PubTator, text mining | PubMed |
| The advancements in targets for ferroptosis in liver diseases. | Front Med (Lausanne) | 2023 | 36999078 | PubTator, text mining | PubMed |
| Regulation of ABC transporters by sex steroids may explain differences in drug resistance between sexes. | J Physiol Biochem | 2023 | 36995571 | PubTator, text mining | PubMed |
| Pharmacogenetics of the Primary and Metastatic Osteosarcoma: Gene Expression Profile Associated with Outcome. | Int J Mol Sci | 2023 | 36982681 | PubTator, text mining | PubMed |
| Influence of Single-Nucleotide Polymorphisms on Clinical Outcomes of Capecitabine-Based Chemotherapy in Colorectal Cancer Patients: A Systematic Review. | Cancers (Basel) | 2023 | 36980706 | PubTator, text mining | PubMed |
| Repurposing Verapamil to Enhance Killing of T-ALL Cells by the mTOR Inhibitor Everolimus. | Antioxidants (Basel) | 2023 | 36978873 | PubTator, text mining | PubMed |
| Molecular mechanisms of anthracycline induced cardiotoxicity: Zebrafish come into play. | Front Cardiovasc Med | 2023 | 36970353 | PubTator, text mining | PubMed |
| Identification of Prognostic Biomarkers for Breast Cancer Metastasis Using Penalized Additive Hazards Regression Model. | Cancer Inform | 2023 | 36968522 | PubTator, text mining | PubMed |
| A novel myeloid cell marker genes related signature can indicate immune infiltration and predict prognosis of hepatocellular carcinoma: Integrated analysis of bulk and single-cell RNA sequencing. | Front Mol Biosci | 2023 | 36959981 | PubTator, text mining | PubMed |
| Biological functions, mechanisms, and clinical significance of circular RNA in colorectal cancer. | Front Oncol | 2023 | 36950552 | PubTator, text mining | PubMed |
| Recombinant Technologies Facilitate Drug Metabolism, Pharmacokinetics, and General Biomedical Research. | Drug Metab Dispos | 2023 | 36948592 | PubTator, text mining | PubMed |
| Anti-proliferative effect of melatonin in human hepatoma HepG2 cells occurs mainly through cell cycle arrest and inflammation inhibition. | Sci Rep | 2023 | 36928762 | PubTator, text mining | PubMed |
| Clinically important alterations in pharmacogene expression in histologically severe nonalcoholic fatty liver disease. | Nat Commun | 2023 | 36927865 | PubTator, text mining | PubMed |
| Effect of polymorphisms in drug metabolism and transportation on plasma concentration of atorvastatin and its metabolites in patients with chronic kidney disease. | Front Pharmacol | 2023 | 36923356 | PubTator, text mining | PubMed |
| A Brief Review on Chemoresistance; Targeting Cancer Stem Cells as an Alternative Approach. | Int J Mol Sci | 2023 | 36901917 | PubTator, text mining | PubMed |
| MicroRNAs as Predictive Biomarkers in Patients with Colorectal Cancer Receiving Chemotherapy or Chemoradiotherapy: A Narrative Literature Review. | Cancers (Basel) | 2023 | 36900159 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10057/papers?page=9